Have cold medicine sales declined during the COVID-19 crisis?
This is just one of the stories from our “I’ve Always Wondered” series, where we tackle all of your questions about the world of business, no matter how big or small. Ever wondered if recycling is worth it? Or how store brands stack up against name brands? Check out more from the series here.
Reader Stefan Dreisbach-Williams from New York City asked:
This is less an “always wondered” than a “keep wondering about lately”: with people social distancing to limit the spread of COVID, have we also limited the spread of common viruses, and has that reduced sales of things like decongestants and cough syrups?
The short answer is: yes. As people wore masks and applied hand sanitizer, and kids stopped going to school, we ended up curbing viruses like the flu.
Cold, flu and cough medicine sales in the U.S. plummeted more than 27% at the end of February 2021 vs. the same period last year, according to data provided by Nielsen.
There were also declines for sinus medicines, which dropped by about 23%, and upper respiratory combination packs, which fell more than 18%.
The total category of upper respiratory medicines — which include all the above categories — declined by roughly 14% and raked in about $8.1 billion in sales over the past year.
Compare that to the previous year, when many of these categories increased in sales. Respiratory aids increased by roughly 19%, while cold and flu medicines increased by about 9%.
In total, upper respiratory medicines increased by 6% and posted about $9.4 billion in sales.
Andrea Wroble, a health & wellness analyst at the market research firm Mintel, said that lockdown measures to control the spread of COVID-19 and better hygiene have halted the spread of seasonal ailments, which has decreased our reliance on over-the-counter medicines.
“Typically communicable illnesses are widespread and contagious, which really positions symptom relief remedies as health necessities,” Wroble said, adding that’s why the market had been so consistent over the past decade.
From Oct. 1, 2020 to Jan. 16, 2021, 136 people were hospitalized for the flu and 292 died in the U.S., according to data from the Centers for Disease Control and Prevention.
“That is minuscule compared to a normal flu season,” said Elizabeth Scott, an associate dean and professor of biology at Simmons University in Boston.
In comparison, between 2019 to 2020, 400,000 people were hospitalized and 22,000 died in the U.S.
Scott said one of the most significant reasons for the flu’s decline is that young children — who are major drivers of its spread — haven’t been going to school.
“There are a number of experts out there who are saying it’s the fact that children are not getting infected and they’re not bringing the flu virus home to the elders in their household,” said Scott, who is also the co-director and founder of the Simmons Center for Hygiene and Health in Home and Community.
Most experts think that flu viruses are spread through tiny droplets when people cough, sneeze or talk, according to the CDC. It’s less common for people to get the flu by touching a surface that has the flu virus on it.
But when it comes to colds, Scott said that the way we typically spread the virus is that we get it onto our hands and then touch our faces. She noted there are studies showing that cold viruses can survive 12 to 24 hours or more on surfaces.
Wroble said that Mintel found that in 2020, 49% of consumers said they experienced a cold in the past 12 months. This year, that figure is down to 30%.
Scott said we’ve been better about practicing hand and surface hygiene, wearing masks (which can inhibit you from touching your face) and we haven’t been out and about as much — all factors that she thinks have helped reduce the spread of common colds.
Major pharmaceutical companies and multinational corporations posted quarterly earnings reports showing how a decrease in cold and flu cases have affected their bottom line.
Tim Chiang, a senior research analyst for Northland Capital Markets, said that the largest manufacturer of over-the-counter medicines in the U.S. is Perrigo, which makes the storebrand medicines you see at Walmart or Walgreens. In the fourth quarter of 2020, net sales for the company decreased by 2.5% because of low levels of the cold and flu.
And Procter & Gamble, which owns Vicks, said it had a decline in sales of respiratory products in the second quarter of 2021, which was “driven by a lower than average incidence of cough, cold and flu this season.”
However, Chiang said that companies that sell over-the-counter medicines are pretty well-diversified.
“They sell hundreds of products. So they usually are able to still generate growth,” he said. “Their customers are gigantic — like Walmart. It’s big companies dealing with big customers.”
Perrigo’s fiscal 2020 net sales increased 5% compared to the previous year, despite those fourth-quarter losses.
Chiang also pointed out that the company Reckitt Benckiser is the parent company of the cold and flu medicine Mucinex and Lysol, which saw increased demand during the pandemic.
Mintel’s Andrea Wroble said that despite the decline in over-the-counter medications, the crisis has “opened the door for a new segment in the illness management market.” That includes products like hand sanitizers, face masks, immune system support supplements and antibacterial cleaners.
“But on the flip side, brands have to consider that consumers are actually experiencing fatigue from constant concern about their health, safety and exposure to illness,” she added.
While the flu decreased this past year, we still have to be vigilant for the upcoming season — especially as the economy reopens.
Scott of Simmons University said that to get a sense of how flu season might look each year, experts look to the opposite hemisphere.
“That’s actually how they make the appropriate flu vaccine every year,” she said.
Which means that as the southern hemisphere gears up to enter winter, they may be able to predict how the flu season might look in the U.S. later this year.
“But there’s absolutely no doubt that people should continue to take their annual flu shot,” Scott added.
COVID-19 Economy FAQs
What do I need to know about tax season this year?
Glad you asked! We have a whole separate FAQ section on that. Some quick hits: The deadline has been extended from April 15 to May 17 for individuals. Also, millions of people received unemployment benefits in 2020 — up to $10,200 of which will now be tax-free for those with an adjusted gross income of less than $150,000. And, for those who filed before the American Rescue Plan passed, simply put, you do not need to file an amended return at the moment. Find answers to the rest of your questions here.
How long will it be until the economy is back to normal?
It feels like things are getting better, more and more people getting vaccinated, more businesses opening, but we’re not entirely out of the woods. To illustrate: two recent pieces of news from the Centers for Disease Control. Item 1: The CDC is extending its tenant eviction moratorium to June 30. Item 2: The cruise industry didn’t get what it wanted — restrictions on sailing from U.S. ports will stay in place until November. Very different issues with different stakes, but both point to the fact that the CDC thinks we still have a ways to go before the pandemic is over, according to Dr. Philip Landrigan, who used to work at the CDC and now teaches at Boston College.
How are those COVID relief payments affecting consumers?
Payments started going out within days of President Joe Biden signing the American Rescue Plan, and that’s been a big shot in the arm for consumers, said John Leer at Morning Consult, which polls Americans every day. “Consumer confidence is really on a tear. They are growing more confident at a faster rate than they have following the prior two stimulus packages.” Leer said this time around the checks are bigger and they’re getting out faster. Now, rising confidence is likely to spark more consumer spending. But Lisa Rowan at Forbes Advisor said it’s not clear how much or how fast.
Marketplace is on a mission.
We believe Main Street matters as much as Wall Street, economic news is made relevant and real through human stories, and a touch of humor helps enliven topics you might typically find…well, dull.
Through the signature style that only Marketplace can deliver, we’re on a mission to raise the economic intelligence of the country—but we don’t do it alone. We count on listeners and readers like you to keep this public service free and accessible to all. Will you become a partner in our mission today?